Duyuru • Jan 31

Symrise AG (XTRA:SY1) completed the acquisition of remaining 30.35% stake in Probi AB (publ) (OM:PROB) from Fourth Swedish National Pension Fund (AP4), Moneta Asset Management and others.

Symrise AG (XTRA:SY1) proposed to acquire remaining 30.35% stake in Probi AB (publ) (OM:PROB) from Fourth Swedish National Pension Fund (AP4), Moneta Asset Management and others for SEK 1.2 billion on November 20, 2024. A cash consideration valued at SEK 350 per share will be paid by Symrise AG. Upon completion, Symrise AG will own 100% stake in Probi AB (publ). If Symrise, whether in connection with the Offer or otherwise, acquires shares representing more than 90 per cent of the total number of shares in Probi, Symrise intends to commence compulsory redemption proceedings under the Swedish Companies Act to acquire all remaining shares in Probi and to promote delisting of Probi’s shares from Nasdaq Stockholm. As of the date, the Symrise owns 7,936,210 shares, corresponding to 69.7 per cent of the outstanding capital and votes in Probi. Fjärde AP-fonden and Moneta Asset Management, have undertaken to accept the Offer and thus to tender 1,057,188 and 960,181 Probi-shares, respectively, in the Offer, representing in aggregate approximately 17.7% of the outstanding capital and votes in Probi. The Offer is not subject to any financing conditions. The cash consideration payable to the Probi's shareholders under the terms of the Offer will be financed by available cash and existing credit facilities of Symrise. The completion of the Offer is conditional upon the Offer being accepted to such an extent that Symrise becomes the owner of shares in Probi representing more than 90 per cent of the total number of shares in Probi on a fully diluted basis; the receipt of all regulatory, governmental or similar clearances, approvals and decisions that are necessary for the Offer and the acquisition of Probi, including from the Swedish Inspectorate of Strategic Products, in each case on terms which, in Symrise’s opinion, are acceptable; no circumstances having occurred which have a material adverse effect or could reasonably be expected to have a material adverse effect on Probi’ financial position, prospects or operations, including Probi’ sales, results, liquidity, equity ratio, equity or assets; neither the Offer nor the acquisition of Probi being rendered wholly or partially impossible or significantly impeded as a result of legislation or other regulation, any decision of a court or public authority, or any similar circumstance; Probi not taking any action that is likely to impair the prerequisites for making or completing the Offer; no information made public by Probi or disclosed by Probi to Symrise being materially inaccurate, incomplete or misleading, and Probi having made public all information which should have been made public by Probi; and no other party announcing an offer to acquire shares in Probi on terms more favourable to the shareholders of Probi than the Offer. The acceptance period is expected to commence on or around December 18, 2024 and expire on or around January 15, 2025. As of November 26, 2024, Symrise has acquired an additional 321,620 shares in Probi (corresponding to 2.8% of the outstanding capital and votes in Probi) in the market at price of SEK 350. Together with the undertakings to accept the Offer obtained from Probi’s shareholders Fjärde APfonden and Moneta Asset Management, respectively, representing in aggregate approximately 17.7% of the outstanding capital and votes in Probi, Symrise has secured approximately 90.2% of the outstanding capital and votes in Probi. As of December 13, 2024, Subject to the foregoing conditions and limitations, it is Grant Thornton’s opinion that the Offer as of this date, from a financial point of view, is fair to the shareholders of Probi. The independent bid committee unanimously recommends the shareholders of Probi to accept the Offer. As of January 2025, Symrise has received clearance from the Swedish Inspectorate of Strategic Products. Therefore, the condition regarding the receipt of all necessary regulatory, governmental or similar clearances, approvals and decisions is fulfilled. The acceptance period for the Offer stated in the offer document expires at January 15, 2025. The acceptance period may be extended. At the end of the acceptance period on January 15, 2025, the Offer had been accepted by shareholders with a total of 2,840,101 shares in Probi, corresponding to 24.9 per cent of the shares and votes in Probi. Since the announcement of the Offer, Symrise has also acquired 321,620 shares in Probi, corresponding to 2.8 per cent of the shares and votes in Probi, at prices not exceeding the Offer Price. As a result, Probi controls in total 11,097,931 shares in Probi, corresponding to 97.4 per cent of the shares and votes in Probi. Symrise has decided to complete the Offer. All conditions are satisfied or have been waived. Settlement for shares tendered in the Offer during the initial acceptance period will be initiated on or around January 20, 2025. Since the Offer is unconditional, shareholders who have already accepted or will accept the Offer during the extended acceptance period to January 29, 2025, have no right to withdraw their acceptances. Symrise intends to initiate compulsory redemption proceedings in accordance with the Swedish Companies Act to acquire all shares not tendered in the Offer and to promote delisting of Probi’s shares from Nasdaq Stockholm. As on January 20, 2025, Symrise has declared its public tender offer to the shareholders of Probi AB unconditional and controls more than 90 per cent of the total number of shares and votes in Probi. Against this background, the shareholders of Probi are hereby officially convened to an Extraordinary General Meeting (“EGM”) which will be held on February 13, 2025. Symrise has retained Lazard as financial advisor and Jesper Schönbeck, Erik Sjöman, Linnéa Sellström, Daniel Wendelsson, and Noelia Martinez of Advokatfirman Vinge KB as legal advisor in connection with the Offer. The independent bid committee of Probi has retained Carnegie Investment Bank AB (publ) as financial adviser and Grant Thornton Sweden AB to render the fairness opinion and Mannheimer Swartling Advokatbyrå as legal adviser. Symrise AG (XTRA:SY1) completed the acquisition of remaining 30.35% stake in Probi AB (publ) (OM:PROB) from Fourth Swedish National Pension Fund (AP4), Moneta Asset Management and others on January 29, 2025. During the extended acceptance period which expired on January 29, 2025, the Offer has been accepted by shareholders with a total of 142,586 shares in Probi, corresponding to 1.3% of the shares and votes in Probi. After the end of the extended acceptance period, Symrise thus controls in total 11,240,517 shares in Probi, corresponding to 98.7% of the shares and votes in Probi. Settlement for shares tendered in the Offer during the extended acceptance period will begin on or around February 3, 2025. Symrise will not further extend the acceptance period for the Offer.

Chemicals Sektör Büyümesi	23.20%
Gelir büyüme oranı	5.62%
Özkaynak getirisi	6.69%
Net Marj	5.01%
Sonraki Kazanç Güncellemesi	29 Oct 2026

Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Jun 26	4,915	246	988	278
31 Mar 26	4,922	248	991	277
31 Dec 25	4,929	249	994	276
30 Sep 25	4,958	378	1,004	279
30 Jun 25	4,987	507	1,013	282
31 Mar 25	4,993	493	1,006	279
31 Dec 24	4,999	478	998	276
30 Sep 24	4,940	435	988	273
30 Jun 24	4,882	392	977	270
31 Mar 24	4,806	366	964	268
31 Dec 23	4,730	340	952	266
30 Sep 23	4,751	290	960	264
30 Jun 23	4,772	239	968	262
31 Mar 23	4,695	259	953	258
31 Dec 22	4,618	280	939	254
30 Sep 22	4,398	344	894	246
30 Jun 22	4,178	408	849	238
31 Mar 22	4,002	391	817	230
31 Dec 21	3,826	375	785	221
30 Sep 21	3,716	354	767	217
30 Jun 21	3,607	334	750	214
31 Mar 21	3,564	320	743	213
31 Dec 20	3,520	307	737	212
30 Sep 20	3,529	311	737	212
30 Jun 20	3,537	314	737	212
31 Mar 20	3,472	303	727	213
31 Dec 19	3,408	291	717	213
30 Sep 19	3,339	285	704	210
30 Jun 19	3,271	279	691	207
31 Mar 19	3,212	277	678	204
31 Dec 18	3,154	275	664	200
30 Sep 18	3,105	273	656	198
30 Jun 18	3,056	271	647	196
31 Mar 18	3,026	271	644	196
31 Dec 17	2,996	270	642	196
30 Sep 17	2,967	265	643	197
30 Jun 17	2,956	260	639	195
31 Mar 17	2,929	257	636	192
31 Dec 16	2,903	252	628	186
30 Sep 16	2,817	241	631	180
30 Jun 16	2,733	247	615	176
31 Mar 16	2,665	245	590	173
31 Dec 15	2,602	247	585	170
30 Sep 15	2,567	224	575	164

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2026/09/11 14:03
Gün Sonu Hisse Fiyatı	2026/09/11 00:00
Kazançlar	2026/06/30
Yıllık Kazançlar	2025/12/31

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

Analist	Kurum
Konstantin Wiechert	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Alexander Sloane	Barclays

Symrise Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

First half 2026 earnings released: EPS: €1.91 (vs €1.92 in 1H 2025)

Symrise AG to Report Q3, 2026 Results on Oct 29, 2026

Full year 2025 earnings released: EPS: €1.78 (vs €3.42 in FY 2024)

Symrise Ag Announces Non Cash Impairment on Investment in Swedencare AB for Fourth Quarter of 2025

Symrise AG to Report Fiscal Year 2025 Results on Mar 04, 2026

First half 2025 earnings released: EPS: €1.92 (vs €1.71 in 1H 2024)

Recent updates

Mutares SE & Co. KGaA (XTRA:MUX) acquired Ameriterpenes, Llc from Symrise AG (XTRA:SY1).

First half 2026 earnings released: EPS: €1.91 (vs €1.92 in 1H 2025)

New minor risk - Financial position

Investor sentiment improves as stock rises 17%

Upcoming dividend of €1.25 per share

Symrise AG, Annual General Meeting, May 06, 2026

Symrise AG to Report Q3, 2026 Results on Oct 29, 2026

New minor risk - Profit margin trend

Full year 2025 earnings released: EPS: €1.78 (vs €3.42 in FY 2024)

Symrise AG announces Annual dividend, payable on May 11, 2026

Investor sentiment improves as stock rises 19%

Symrise Ag Announces Non Cash Impairment on Investment in Swedencare AB for Fourth Quarter of 2025

New minor risk - Share price stability

Symrise AG to Report Fiscal Year 2025 Results on Mar 04, 2026

Now 21% undervalued after recent price drop

First half 2025 earnings released: EPS: €1.92 (vs €1.71 in 1H 2024)

Symrise AG, Annual General Meeting, May 20, 2025

Full year 2024 earnings released: EPS: €3.42 (vs €2.44 in FY 2023)

Symrise AG Proposes Dividend for the Fiscal Year 2024

Now 21% undervalued after recent price drop

Symrise AG (XTRA:SY1) completed the acquisition of remaining 30.35% stake in Probi AB (publ) (OM:PROB) from Fourth Swedish National Pension Fund (AP4), Moneta Asset Management and others.

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Symrise AG to Report Fiscal Year 2024 Results on Jan 30, 2025

Symrise AG to Report Q1, 2025 Results on Apr 29, 2025

Now 21% overvalued

First half 2024 earnings released: EPS: €1.71 (vs €1.34 in 1H 2023)

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri Kaynakları

Analiz Modeli ve Kar Tanesi

Endüstri ve Sektör Metrikleri

Analist Kaynakları